Literature DB >> 16679078

Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.

Ming-Jui Hung1, Wen-Jin Cherng, Chi-Wen Cheng, Li-Fu Li.   

Abstract

Serum levels of inflammatory markers (interleukin-6, monocyte chemoattractant protein-1, soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and C-reactive protein) were measured at baseline in serum samples from 189 patients who were admitted for coronary angiography because of suspected ischemic heart disease. Median duration of follow-up was 28 months. Patients in our sample were enrolled in 4 diagnostic groups: no hemodynamically significant coronary artery disease (CAD) and no coronary vasospasm (control group, n = 32), hemodynamically significant CAD and stable angina pectoris (SAP group, n = 34), coronary vasospastic angina pectoris without hemodynamically significant CAD (vasospasm group, n = 31), and acute coronary syndrome (ACS) and hemodynamically significant CAD (ACS group, n = 92). Overall, the level of serum inflammatory markers was highest in the ACS group and lowest in the control group, with intermediate values observed in the SAP and vasospasm groups, with the exception of soluble intercellular adhesion molecule-1, the level of which was highest in the vasospasm group. Multivariate analysis showed that log (interleukin-6) was independently associated with a diagnosis of coronary vasospastic angina pectoris in patients without hemodynamically significant CAD (odds ratio 8.48, p = 0.027). Patients in the ACS group had a significantly lower survival rate compared with the other 3 groups but without an independent predictor that could be identified in this patient cohort. Recurrent angina pectoris occurred with similar rates in the SAP, vasospasm, and ACS groups. The independent predictor for recurrent angina pectoris was treatment that did not include clopidogrel (odds ratio 3.88, p = 0.007). In conclusion, the results of this study suggest that inflammation can exist in coronary vasospasm without hemodynamically significant CAD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679078     DOI: 10.1016/j.amjcard.2005.12.035

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

Review 1.  Clinical utility of novel biomarkers for cardiovascular disease risk stratification.

Authors:  Maurizio Averna; Davide Noto
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

Review 2.  Variant Angina and Aborted Sudden Cardiac Death.

Authors:  Amartya Kundu; Aditya Vaze; Partha Sardar; Ahmed Nagy; Wilbert S Aronow; Naomi F Botkin
Journal:  Curr Cardiol Rep       Date:  2018-03-08       Impact factor: 2.931

3.  An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.

Authors:  Vijay Kunadian; Alaide Chieffo; Paolo G Camici; Colin Berry; Javier Escaned; Angela H E M Maas; Eva Prescott; Nicole Karam; Yolande Appelman; Chiara Fraccaro; Gill Louise Buchanan; Stephane Manzo-Silberman; Rasha Al-Lamee; Evelyn Regar; Alexandra Lansky; J Dawn Abbott; Lina Badimon; Dirk J Duncker; Roxana Mehran; Davide Capodanno; Andreas Baumbach
Journal:  Eur Heart J       Date:  2020-10-01       Impact factor: 29.983

4.  Current advances in the understanding of coronary vasospasm.

Authors:  Ming-Jui Hung
Journal:  World J Cardiol       Date:  2010-02-26

5.  Interleukin-6 promotor polymorphisms and coronary vasospastic angina in Han Chinese.

Authors:  Ying Wang; Gang Li; Ya-Min Su; Hai-Yan Pan; Hai-Hua Geng; Meng-Kan Fan; Min Pan
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 6.  Coronary Vasospastic Angina: Current Understanding and the Role of Inflammation.

Authors:  Ming-Jui Hung; Wen-Jin Cherng
Journal:  Acta Cardiol Sin       Date:  2013-01       Impact factor: 2.672

7.  Use of gallium 67 scintigraphy to differentiate acute myocarditis from acute myocardial infarction.

Authors:  Ming-Yow Hung; Ming-Jui Hung; Chi-Wen Cheng
Journal:  Tex Heart Inst J       Date:  2007

Review 8.  A pathophysiological compass to personalize antianginal drug treatment.

Authors:  Edoardo Bertero; Gerd Heusch; Thomas Münzel; Christoph Maack
Journal:  Nat Rev Cardiol       Date:  2021-07-07       Impact factor: 32.419

9.  Chronic kidney disease stage is a modulator on the association between high-sensitivity C-reactive protein and coronary vasospastic angina.

Authors:  Heng-Jung Hsu; Chiung-Hui Yen; Kuang-Hung Hsu; I-Wen Wu; Chin-Chan Lee; Chiao-Yin Sun; Chia-Chi Chou; Chun-Yu Chen; Shih-Ying Yang; Chi-Jen Tsai; Mai-Szu Wu; Ming-Jui Hung
Journal:  ScientificWorldJournal       Date:  2014-03-05

10.  Impact of Asthma on the Development of Coronary Vasospastic Angina: A Population-Based Cohort Study.

Authors:  Ming-Jui Hung; Chun-Tai Mao; Ming-Yow Hung; Tien-Hsing Chen
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.